Detalles de la búsqueda
1.
Interobserver Variation in the Assessment of Immunohistochemistry Expression Levels in HER2-Negative Breast Cancer: Can We Improve the Identification of Low Levels of HER2 Expression by Adjusting the Criteria? An International Interobserver Study.
Mod Pathol
; 36(1): 100009, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36788064
2.
Stromal Changes are Associated with High P4HA2 Expression in Ductal Carcinoma in Situ of the Breast.
J Mammary Gland Biol Neoplasia
; 26(4): 367-375, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-35076865
3.
Interobserver variability in the assessment of stromal tumor-infiltrating lymphocytes (sTILs) in triple-negative invasive breast carcinoma influences the association with pathological complete response: the IVITA study.
Mod Pathol
; 34(12): 2130-2140, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34218258
4.
Interobserver variability in upfront dichotomous histopathological assessment of ductal carcinoma in situ of the breast: the DCISion study.
Mod Pathol
; 33(3): 354-366, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-31534203
5.
Dichotomous histopathological assessment of ductal carcinoma in situ of the breast results in substantial interobserver concordance.
Histopathology
; 73(6): 923-932, 2018 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-30168167
6.
HER2 protein overexpression in non-amplified ductal carcinoma in situ: quality issue or transcription mechanisms gone awry?
Histopathology
; 74(4): 666-668, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30480328
7.
Bone marrow-derived mesenchymal stem cells promote colorectal cancer progression through paracrine neuregulin 1/HER3 signalling.
Gut
; 62(4): 550-60, 2013 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-22535374
8.
A nanobody targeting the F-actin capping protein CapG restrains breast cancer metastasis.
Breast Cancer Res
; 15(6): R116, 2013 Dec 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-24330716
9.
Vacuolar H+ ATPase expression and activity is required for Rab27B-dependent invasive growth and metastasis of breast cancer.
Int J Cancer
; 133(4): 843-54, 2013 Aug 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-23390068
10.
Stromal architecture and periductal decorin are potential prognostic markers for ipsilateral locoregional recurrence in ductal carcinoma in situ of the breast.
Histopathology
; 63(4): 520-33, 2013 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-23889174
11.
Completion surgery after intensity-modulated arc therapy in the treatment of locally advanced cervical cancer: feasibility, surgical outcome, and oncologic results.
Int J Gynecol Cancer
; 23(5): 877-83, 2013 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-23698797
12.
Value of magnetic resonance and ¹8FDG PET-CT in predicting tumor response and resectability of primary locally advanced cervical cancer after treatment with intensity-modulated arc therapy: a prospective pathology-matched study.
Int J Gynecol Cancer
; 22(4): 630-7, 2012 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-22237382
13.
The Baader-Meinhof phenomenon in ductal carcinoma in situ of the breast.
Histopathology
; 69(3): 522-3, 2016 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-27028714
14.
Fine tuning of the Van Nuys prognostic index (VNPI) 2003 by integrating the genomic grade index (GGI): new tools for ductal carcinoma in situ (DCIS).
Breast J
; 17(4): 343-51, 2011.
Artículo
en Inglés
| MEDLINE | ID: mdl-21645166
15.
Comparison of the tumor immune microenvironment of primary hormone receptor-negative HER2-positive and triple negative breast cancer.
NPJ Breast Cancer
; 7(1): 128, 2021 Sep 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-34556657
16.
A single-cell map of intratumoral changes during anti-PD1 treatment of patients with breast cancer.
Nat Med
; 27(5): 820-832, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33958794
17.
Comparison of miRNA profiles of microdissected Hodgkin/Reed-Sternberg cells and Hodgkin cell lines versus CD77+ B-cells reveals a distinct subset of differentially expressed miRNAs.
Br J Haematol
; 147(5): 686-90, 2009 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-19775296
18.
Prognostic significance of oncogenic markers in ductal carcinoma in situ of the breast: a clinicopathologic study.
Breast J
; 15(2): 120-32, 2009.
Artículo
en Inglés
| MEDLINE | ID: mdl-19292797
19.
Stromal characteristics are adequate prognosticators for recurrence risk in ductal carcinoma in situ of the breast.
Eur J Surg Oncol
; 45(4): 550-559, 2019 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30454971
20.
A plea for appraisal and appreciation of immunohistochemistry in the assessment of prognostic and predictive markers in invasive breast cancer.
Breast
; 37: 52-55, 2018 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-29100044